Medically reviewed by Isabel Casimiro, MD, PhD Type 1.5 diabetes is a controversial diagnosis that combines features of the ...

Ekberg and colleagues proposed that in type 1 diabetes a deficiency of C peptide, a subunit of the proinsulin molecule, also contributes to nerve damage; their animal studies showed that C-peptide ...

Four weeks after transplantation, the study showed the survival and function of transplanted pancreatic beta cells, evidenced by circulating C-peptide levels, which indicate insulin production.

remaining beta-cell mass as assessed by C peptide (a cleavage product generated and measurable in peripheral blood during insulin production) and the severity of complications. Any single animal ...

Cour Pharmaceuticals Development Co. Inc. has obtained IND clearance from the FDA for CNP-103, a nanoparticle in development to address the underlying autoimmunity of type 1 diabetes. A first-in-human ...

Dr Samet Sahin from the School of Engineering has received £406,000 funding to develop a simple tool to allow healthcare professionals to quickly and ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...